Gracell Biotechnologies to Participate in Four Upcoming Investor Conferences

Rhea-AI Summary

Gracell Biotechnologies Inc. (NASDAQ: GRCL) announced participation in four investor conferences in September 2022. Key events include the Wells Fargo Healthcare Conference from September 7-9, featuring a fireside chat on September 7 at 9:45 a.m. ET, and the Citi's 17th Annual BioPharma Conference from September 6-8, with a panel presentation on September 8 at 11:20 a.m. ET. Other conferences include the H.C. Wainwright Conference and the Cantor Call on September 15. Webcasts will be available for 30 days after the events.

SAN DIEGO, Calif., and SUZHOU and SHANGHAI, China, Aug. 29, 2022 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to discovering and developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced that the management team will participate in and attend one-on-one meetings at four investor conferences in September 2022 as follows:

Wells Fargo Healthcare Conference 2022 (September 7 – 9, 2022)
Fireside Chat: September 7 at 9:45 a.m. ET
One-on-one meetings: Wednesday, September 7, 2022
Location: Boston, MA

Citi's 17^th Annual BioPharma Conference (September 6 – 8, 2022)
Panel Presentation: September 8 at 11:20 a.m. ET
One-on-one meetings: Thursday, September 8, 2022
Location: Boston, MA

H.C. Wainwright 24^th Annual Global Investment Conference (September 12 – 16, 2022)
Presentation: September 12 at 3:30 p.m. ET
One-on-one meetings: Monday, September 12 & Friday, September 16, 2022
Location: New York, NY and Virtual

Cantor Call and Genetic Medicines Conference (September 15, 2022)
Panel Presentation: September 15 at 10:40 a.m. ET
One-on-one meetings: September 15, 2022
Location: New York, NY

Webcast of the presentations will be available on the News and Events section of Gracell's investor website. A replay of the webcast will be available for 30 days following the event.

About Gracell
Gracell Biotechnologies Inc. ("Gracell") is a global clinical-stage biopharmaceutical company dedicated to discovering and developing breakthrough cell therapies. Leveraging its pioneering FasTCAR and TruUCAR technology platforms and SMART CART™ technology module, Gracell is developing a rich clinical-stage pipeline of multiple autologous and allogeneic product candidates with the potential to overcome major industry challenges that persist with conventional CAR-T therapies, including lengthy manufacturing time, suboptimal cell quality, high therapy cost and lack of effective CAR-T therapies for solid tumors. For more information on Gracell, please visit www.gracellbio.com and follow @GracellBio on LinkedIn.

Media contact
Marvin Tang
marvin.tang@gracellbio.com

Investor contact
Gracie Tong
gracie.tong@gracellbio.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/gracell-biotechnologies-to-participate-in-four-upcoming-investor-conferences-301613526.html

SOURCE Gracell Biotechnologies Inc.

FAQ

What investor conferences will Gracell (GRCL) attend in September 2022?

Gracell will attend the Wells Fargo Healthcare Conference, Citi's 17th Annual BioPharma Conference, H.C. Wainwright 24th Annual Global Investment Conference, and Cantor Call and Genetic Medicines Conference.

When is the fireside chat for the Wells Fargo Healthcare Conference for Gracell (GRCL)?

The fireside chat for the Wells Fargo Healthcare Conference will take place on September 7, 2022, at 9:45 a.m. ET.

Where is Gracell's participation in the Citi's 17th Annual BioPharma Conference located?

Gracell's participation in the Citi's 17th Annual BioPharma Conference will be held in Boston, MA.

What is the date for the presentations at the H.C. Wainwright Conference for Gracell (GRCL)?

Gracell's presentation at the H.C. Wainwright Conference is scheduled for September 12, 2022, at 3:30 p.m. ET.

Will there be webcasts available for Gracell's investor presentations?

Yes, webcasts of the presentations will be available on Gracell's investor website for 30 days following the events.